ストックスクリーナーアプリを入手
0.2259
2.59%
0.0057
プレマーケット:
.22
-0.0059
-2.61%
前日終値:
$0.2202
開ける：
$0.23
24時間の取引高:
161.51K
Relative Volume:
0.02
時価総額：
$5.76M
収益：
$357.90K
当期純損益:
$-11.06M
株価収益率:
-0.2017
EPS:
-1.1201
ネットキャッシュフロー:
$-11.90M
1週間 パフォーマンス:
+10.74%
1か月 パフォーマンス:
-31.55%
6か月 パフォーマンス:
-20.74%
1年 パフォーマンス:
-84.94%
1日の値動き範囲:
$0.2226
$0.235
1週間の範囲:
$0.201
$0.236
52週間の値動き範囲:
$0.1593
$1.89
Biorestorative Therapies Inc Stock (BRTX) Company Profile
名前
Biorestorative Therapies Inc
セクター
電話
(631) 760-8100
住所
40 MARCUS DRIVE, MELVILLE
Compare BRTX vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
0.2259 | 5.41M | 357.90K | -11.06M | -11.90M | -1.1201 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Biorestorative Therapies Inc (BRTX) 最新ニュース
BioRestorative Therapies suspends shipments of ExoCR and BioX products for review - Investing.com
Form 8K BioRestorative Therapies Inc For: 14 August By Investing.com - Investing.com Nigeria
BioRestorative Therapies Delays Quarterly SEC Filing - TipRanks
BioRestorative Therapies Halts ExoCR and BioX Shipments - TipRanks
Biorestorative Therapies Suspends All Orders, Shipments Of Exocr, Biox Biocosmeceutical Product Lines Effective Immediately, On Aug 7 - TradingView
BioRestorative Therapies (BRTX) delays Q2 10-Q amid losses and going-concern risk - Stock Titan
BRTX Q2'26 Earnings: revenue estimate is 600.00K USD - TradingView
BioRestorative Therapies Inc (BRTX) Stock News Today - tradingkey.com
BioRestorative Therapies Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
BioRestorative Therapies Inc (BRTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioRestorative Therapies (BRTX) investor Alta Partners reports 4.99% ownership cap - Stock Titan
BioRestorative Therapies (BRTX) reports director Esha Randhawa’s insider status - Stock Titan
BioRestorative Therapies Inc - TradingKey
BioRestorative Therapies Inc (BRTX) Balance Sheet - TradingKey
BioRestorative Therapies Inc (BRTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioRestorative Therapies Inc (BRTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
BioRestorative Therapies Inc (BRTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BRTX|BioRestorative Therapies Inc|Price:0.219|Chg%:+0.018 - TradingKey
BioRestorative Therapies Inc (BRTX) Cash Flow - TradingKey
BioRestorative Therapies Inc (BRTX) Income Statement - tradingkey.com
BRTX|BioRestorative Therapies Inc|Price:0.270|Chg%:-0.007 - TradingKey
BioRestorative Therapies Inc (BRTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BRTX|BioRestorative Therapies Inc|Price:0.282|Chg%:-0.008 - TradingKey
BRTX|BioRestorative Therapies Inc|Price:0.226|Chg%:+0.006 - TradingKey
BioRestorative Therapies, Inc. Revenue Breakdown – GETTEX:9OF - TradingView
Biorestorative Therapies Company Profile & Introduction - Moomoo
BioRestorative Therapies (BRTX) Q1 2026 Earnings: Narrower Loss Beats Estimates as Company Advances PipelineAnnual Financial Report - dars.gov.et
BioRestorative Therapies Announces Amendments to Executive Employment Agreements in July 2026 - Minichart
Leadership shake-up at Biorestorative Therapies (NASDAQ: BRTX) and new CEO - Stock Titan
BioRestorative Therapies, Inc. Announces CFO Changes, Effective July 13, 2026 - marketscreener.com
BioRestorative Therapies (BRTX) Bounces from Support, Stages 3.5% RecoveryOBV Divergence - dars.gov.et
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
BioRestorative Therapies (BRTX) Slips 2.55% as Stock Approaches Crucial Support ZoneOpening Range Breakout - dars.gov.et
Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) - AOL.com
Price to book forward of BioRestorative Therapies, Inc. – GETTEX:9OF - TradingView
BioRestorative Therapies (BRTX) Slides 1% to $0.40, Tests Key Support Amid Low VolumeWyckoff Upthrust - dars.gov.et
BRTX Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline Amid Clinical Progress - dars.gov.et
Here's why Biorestorative Therapies (BRTX) looks ripe for bottom fishing - MSN
BioRestorative Therapies, Inc.'s Equity Buyback announced on August 12, 2025, has expired. - marketscreener.com
BioRestorative Therapies (BRTX) Rises 1.62% as Stock Holds Above Key Support at $0.36Volatility Stop - DonanımHaber
Enterprise value to EBITDA forward of BioRestorative Therapies, Inc. – NASDAQ:BRTX - TradingView
Price to earnings forward of BioRestorative Therapies, Inc. – NASDAQ:BRTX - TradingView
Price to earnings forward of BioRestorative Therapies, Inc. – TRADEGATE:9OF - TradingView
BioRestorative (NASDAQ:BRTX) Gains Penny Stock Attention - Kalkine Media
Enterprise value to revenue forward of BioRestorative Therapies, Inc. – NASDAQ:BRTX - TradingView
Enterprise value to revenue forward of BioRestorative Therapies, Inc. – TRADEGATE:9OF - TradingView
Price to book forward of BioRestorative Therapies, Inc. – NASDAQ:BRTX - TradingView
Price to sales forward of BioRestorative Therapies, Inc. – TRADEGATE:9OF - TradingView
Price to book forward of BioRestorative Therapies, Inc. – TRADEGATE:9OF - TradingView
BioRestorative Therapies, Inc. Actuals & Estimates (NASDAQ:BRTX) - TradingView
BRTX Forecast — Price Target — Prediction for 2027 - TradingView
Biorestorative Therapies Inc (BRTX) 財務データ
収益
当期純利益
現金流量
EPS
0.52%
0.07%
大文字化:
|
ボリューム (24 時間):